New gel could make Kids' tonsil surgery recovery less painful

NCT ID NCT07188779

Recruiting now Symptom relief Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study tests whether applying RADA16 hydrogel to the surgical site during tonsillectomy reduces pain and bleeding in children aged 3-17. Half the children will get the gel, half will not. Families will track symptoms via online surveys for 30 days after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RADA16 hydrogel (a self-assembling peptide gel applied to the surgical site)
What this could lead to: If it works, this gel could become a standard way to reduce pain and bleeding after tonsillectomy in children, speeding recovery.
What could go wrong: This is a small Phase 2 trial, so results are preliminary. The gel may not significantly improve outcomes, and there is a risk of allergic reaction or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE PAIN

Contacts and locations

Locations

Cooperman Barnabas Medical Center
NOT_YET_RECRUITING

Livingston, New Jersey, 07039, United States
University Hospital
RECRUITING

Newark, New Jersey, 07103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.